Effect of pimobendan on end-stage heart failure in a mouse model of inherited dilated cardiomyopathy

被引：0
|
作者：
Nonaka, Miki [1 ]
Morimoto, Sachio [1 ]
机构：
[1] Kyushu Univ, Fac Med Sci, Dept Clin Pharmacol, Fukuoka, Fukuoka, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2015年 / 128卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
MS2F-3-3
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [1] Therapeutic effect of pimobendan on end-stage heart failure in a mouse model of dilated cardiomyopathy
    Nonaka, Miki
    Morimoto, Sachio
    Li, Lei
    Kitamura, Yutaka
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 241P - 241P
  • [2] Effect of Pimobendan on Heart Failure in a Mouse Model Inherited Cardiomyopathy
    Nonaka, Miki
    Hayamizu, Kengo
    Morimoto, Sachio
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 343A - 343A
  • [3] Effect of pimobendan on heart failure at different stages in a mouse model of inherited cardiomyopathy
    Nonaka, Miki
    Morimoto, Sachio
    Hayamizu, Kengo
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 106P - 106P
  • [4] Genotype influences end-stage heart failure occurrence in dilated cardiomyopathy
    Cannie, D.
    Bakalakos, A.
    Protonotarios, A.
    Syrris, P.
    Lorenzini, M.
    Guttmann, O.
    O'mahony, C.
    Savvatis, K.
    Lopes, L.
    Sekhri, N.
    Mohiddin, S.
    Elliott, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [5] Restrictive mitral annuloplasty for end-stage heart failure due to idiopathic dilated cardiomyopathy
    Saito, Shunsuke
    Matsumiya, Goro
    Sakaguci, Taichi
    Fujita, Tomoyuki
    Takeda, Koji
    Taniguchi, Kazuhiro
    Masai, Takafumi
    Sakata, Yasushi
    Sawa, Yoshiki
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (07) : S155 - S155
  • [6] TREATMENT OF END-STAGE DILATED CARDIOMYOPATHY
    OCONNELL, JB
    MOORE, CK
    WATERER, HC
    BRITISH HEART JOURNAL, 1994, 72 (06): : S52 - S56
  • [7] Challenges of Palliative Treatment for End-Stage Heart Failure "From a Report of Severe Heart Failure Due to Dilated Cardiomyopathy"
    Oishi, Shogo
    Toba, Takayoshi
    Miyoshi, Naoki
    Takaya, Tomofumi
    Tsukishiro, Yasue
    Yamada, Shinichiro
    Taniguchi, Yasuyo
    Hayashi, Takatoshi
    Yokoyama, Mitsuhiro
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S177 - S177
  • [8] Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy
    Zhu, Xiaoming
    Wang, Hongjiang
    Liu, Fan
    Chen, Li
    Luo, Weijia
    Su, Pixiong
    Li, Weiming
    Yu, Liping
    Yang, Xinchun
    Cai, Jun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (09) : 1173 - 1187
  • [9] Pimobendan has a preventive effect on compensated heart failure but increases the risk of sudden cardiac death at end-stage heart failure
    Nonaka, Miki
    Morimoto, Sachio
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 241P - 241P
  • [10] THE ROLE OF MYOCARDITIS IN END-STAGE DILATED CARDIOMYOPATHY
    OCONNELL, JB
    TEXAS HEART INSTITUTE JOURNAL, 1987, 14 (03) : 268 - 275
12345